Portfolio concentration
As of January 31, 2026 · N-PORT
Holdings
10
Top-10 weight
100.00%
Effective holdings
?
The number of equal-weight positions that would produce this portfolio's concentration (1 ÷ Herfindahl index). A 500-stock fund dominated by a few mega-caps might have only ~100 effective holdings.
6
Crowding
?
The value-weighted average number of funds that also own this fund's positions. High = consensus/crowded picks; low = holdings few other funds own.
538.0
Holdings
As of January 31, 2026 · N-PORT| # | Security | Ticker | Shares | Value | % of fund |
|---|---|---|---|---|---|
| 1 | FRST AM-GV OB-X | TMPXX | 15,720,155 | $15.72M | 30.37% |
| 2 | CHART INDUSTRIES INC | — | 31,101 | $6.45M | 12.46% |
| 3 | AVIDITY BIOSCIENCES | — | 88,743 | $6.44M | 12.44% |
| 4 | EXACT SCIENCES CORP | — | 62,859 | $6.43M | 12.43% |
| 5 | BRIGHTHOUSE FINANCIAL INC | — | 100,227 | $6.42M | 12.41% |
| 6 | PENUMBRA INC | — | 6,992 | $2.50M | 4.84% |
| 7 | CONFLUENT INC-A | — | 80,717 | $2.47M | 4.76% |
| 8 | CANTALOUPE INC | — | 223,215 | $2.40M | 4.63% |
| 9 | BIOCRYST PHARMACEUTICALS INC | — | 73,504 | $483.65K | 0.93% |
| 10 | US ULTRA BOND CBT Sep25 | — | 1 | $10.68K | 0.02% |
| 11 | US ULTRA BOND CBT Sep25 | — | 1 | -$6.21K | -0.01% |
| 12 | US ULTRA BOND CBT Sep25 | — | 62 | -$10.66K | -0.02% |
| 13 | US ULTRA BOND CBT Sep25 | — | 119 | -$56.18K | -0.11% |
| 14 | US ULTRA BOND CBT Sep25 | — | 116 | -$90.81K | -0.18% |
| 15 | US ULTRA BOND CBT Sep25 | — | 112 | -$117.29K | -0.23% |
| 16 | BIOCRYST PHARMACEUTICALS INC | — | -73,503 | -$483.65K | -0.93% |
| 17 | BOSTON SCIENTIFIC CORP | — | -18,571 | -$1.74M | -3.36% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.